TSE: 7780 - Menicon Co., Ltd.

Yield per half year: -4%
Dividend yield: +3.29%
Sector: Healthcare

Menicon Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
28.89 110.66 -73.89% 36.01 -19.78%
P/S 1.13 75.01 -98.5%
P/BV 1.6 70.3 -97.72%
P/FCF -20 79.52 -125.15%
Ev/Ebitda 9.86 18.65 -47.12%
Ev/S 1.34 72.39 -98.16%
Ev/FCF -16.39 24.55 -166.75%
E/P 0.024 -0.1123 -121.38%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
13.54 -77.27 -117.53% 15.96 -15.14%
ROE 5.8 -9.19 -163.14%
ROA 2.73 -9.6 -128.45%
ROIC 7.24 9.09 -20.4%
ROS 3.91 -143.83 -102.72%
ROCE 6 6.01 -0.1811%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
2/10
4.5 -1.04 -531.97% 3.46 +29.98%
Nеt Debt/Ebitda 1.53 12.09 -87.34%
Debt/Ratio 0.3937 0.1394 182.35%
Debt/Equity 1.24 18.09 -93.15%
Debt/Net Income 15.6 -1.95 -900.69%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
8.23/10
3.29 2.66 23.57% 1.25 +162.57%
Number of years of dividend growth 2 1.27 57.45%
DSI 0.9286 0.7328 26.72%
Average dividend growth -18.63 -49.62 -62.45%
Average percentage for 5 years 1.25 1.91 -34.5%
Average percentage for payments 24.92 33.37 -25.32%
Difference from average difference in sector 0.6276

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
37.47 53.88 -30.46%
Growth impulse Ebitda in 5 years 29.42 12.48 135.74%
Growth impulse Net Income in 5 years 11.77 -8.53 -237.98%
Growth impulse FCF in 5 years -522.68 -13.75 3701.31%
Growth impulse EPS in 5 years 2.61 -67.8 -103.85%
IP Score
4.46/10

Similar companies

Astellas Pharma Inc.

Takeda Pharmaceutical Company Limited

HOYA Corporation

Daiichi Sankyo Company, Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription